H-NIP News

Read About Our Impact: Check out these summaries of the H-NIP project and the National HIV Curriculum:

• National HIV Curriculum Summary Data 18-045 Integration Project: H-NIP. February 2023.
• National HIV Curriculum Summary Data. February 2023.

H-NIP Summer 2022 Newsletter. Read about how H-NIP partners have stepped up to the plat to battle the COVID-19 pandemic along with voices from the field and impact felt across the country.

Sunday, June 27, 2021, we recognize another important observance: National HIV Testing Day (NHTD). This day is an opportunity to encourage and emphasize the importance of HIV testing, which is essential to reducing HIV infections, improving health outcomes for people with HIV, and helping to end the HIV epidemic in the U.S.

Live with Leadership - 40 Years of HIV: Federal Leadership. The HHS Office of Infectious Disease and HIV/AIDS Policy (OIDP) will hold a Live with Leadership conversation about 40 Years of HIV: Federal Leadership.

Ryan White HIV/AIDS Program (RWHAP) COVID-19 Data Report, January 20, 2020 through December 31, 2020. This report is HRSA HAB’s first publication of national RWHAP aggregate-level data submitted through the CDR. Data are presented for January 20, 2020 through December 31, 2020.  Because data can be submitted on a retroactive and rolling basis, data presented are based on those submitted as of February 23, 2021, to allow time for the more recent months’ data to stabilize. Due to the ongoing nature of CDR reporting, however, the data contained in the report should be considered preliminary.

H-NIP Launches Google Group. This Google Group has been created for HBCU Health Professions graduates who have completed at least one module of the National HIV Curriculum (NHC). The project intends to use this Google Group to check in with you quarterly and find out if you are practicing HIV clinical care or intending to do so; any obstacles that you face in trying to practice HIV clinical care; and any information or capacity building needs you have relative to HIV clinical care. Read more

Ryan White HIV/AIDS Program 2018 State Profiles. The 2018 State Profiles is an online resource that provides users with a national and state-by-state look at the newly released Ryan White HIV/AIDS Program Services Report (RSR) client-level data for 2018. The data visualization tool offers a detailed look at national and state-level information on Ryan White HIV/AIDS Program recipients, providers, and clients. Read more

HVTN 702 clinical trial of an HIV vaccine stopped. The United States National Institutes of Health has announced that its HVTN 702 clinical trial of an HIV vaccine has been stopped. While no safety concerns were found during the trial, the independent data and safety monitoring board found that the vaccine was ineffective in preventing HIV transmission. Read press release

H-NIP is promoted by the Student National Medical Association. Omonivie H. Agboghidi, MD and MPH Candidate and National President of the Student National Medical Association, used her organization's President's Newsletter to promote H-NIP's online courses. Read her full message here

Pharmacists Can Play Key Role in Ending the HIV Epidemic. In August 2014, the Centers for Disease Control and Prevention, Walgreens, and the University of North Texas Health Science Center’s System College of Pharmacy implemented the Patient-centered HIV Care Model. The goal of the model was to integrate community-based HIV-trained pharmacists with primary medical providers to provide patient-centered care for people with HIV and improve retention in HIV care, adherence to ART, and HIV viral suppression. Read more about the findings and what they mean for ending HIV... Read the HIV.gov article on pharmacists.

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U1OHA32108, Howard University: Integrating the National HIV Curriculum e-Learning Platform into Health Care Provider Professional Education (H-NIP) in the amount of $2.4M and with 0% financed with nongovernmental sources. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.